MoonLake Immunotherapeutics Operating Lease, Liability in USD from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
MoonLake Immunotherapeutics quarterly Operating Lease, Liability history and growth rate from Q4 2021 to Q3 2025.
  • MoonLake Immunotherapeutics Operating Lease, Liability for the quarter ending September 30, 2025 was $1.99M, a 41.3% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)

MoonLake Immunotherapeutics Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.99M -$1.4M -41.3% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $2.39M -$958K -28.6% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $2.57M -$1.09M -29.7% Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $2.83M -$868K -23.5% Dec 31, 2024 10-K 2025-02-26
Q3 2024 $3.38M +$3.21M +1895% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.34M +$3.13M +1483% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.66M +$3.42M +1387% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.7M +$3.42M +1209% Dec 31, 2023 10-K 2024-02-29
Q3 2023 $169K Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $211K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $246K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $283K -$152K -35% Dec 31, 2022 10-K 2023-03-20
Q4 2021 $435K Jan 1, 2022 10-K 2023-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.